Calunsag, Sofia .
HRN: 26-11-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/22/2024
11/01/2024
IV
200mg
Q8h
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes